These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8105491)

  • 21. Modification of the behavioural effects of amineptine after acute, subacute and chronic administration of phenobarbital in mice.
    De Angelis L
    In Vivo; 1989; 3(5):331-4. PubMed ID: 2519874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amineptine: its effect on the dopaminergic system of rats.
    Ponzio F; Achilli G; Garattini S; Perego C; Sacchetti G; Algeri S
    J Pharm Pharmacol; 1986 Apr; 38(4):301-3. PubMed ID: 2872297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Although chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake inhibitor.
    Vaugeois JM; Corera AT; Deslandes A; Costentin J
    Pharmacol Biochem Behav; 1999 Jun; 63(2):285-90. PubMed ID: 10371658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying the molecular structure of behavior: separate effects of caffeine, cocaine, and adenosine agonists on interresponse times and lever-press durations.
    Newland MC
    Behav Pharmacol; 1997 Feb; 8(1):1-16. PubMed ID: 9832996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The differential effects of post-session administration of amineptine and imipramine on memory processes in mice.
    de Angelis L
    Methods Find Exp Clin Pharmacol; 1990; 12(1):23-7. PubMed ID: 2314150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of dopamine in reinforcement: changes in reinforcement sensitivity induced by D1-type, D2-type, and nonselective dopamine receptor agonists.
    Bratcher NA; Farmer-Dougan V; Dougan JD; Heidenreich BA; Garris PA
    J Exp Anal Behav; 2005 Nov; 84(3):371-99. PubMed ID: 16596971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice.
    Tyhon A; Lakaye B; Grisar T; Tirelli E
    Pharmacol Biochem Behav; 2008 Feb; 88(4):446-55. PubMed ID: 17996928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-tolerance between amineptine, an atypical antidepressant and cocaine in mice.
    Filibeck U; Castellano C; Oliverio A
    Funct Neurol; 1988; 3(2):129-36. PubMed ID: 3402812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs.
    O'Donnell JM; Seiden LS
    J Pharmacol Exp Ther; 1983 Jan; 224(1):80-8. PubMed ID: 6848751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of Parkinson syndrome secondary to combined amineptine and bromazepam abuse].
    Lapaz AG; Pozo P; Romero H; Barcia D
    Encephale; 1998; 24(5):486-8. PubMed ID: 9850824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.
    Hillhouse TM; Porter JH
    Behav Pharmacol; 2014 Feb; 25(1):80-91. PubMed ID: 24370559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
    O'Donnell JM; Marek GJ; Seiden LS
    Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
    Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
    J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment.
    Srisurapanont M; Jarusuraisin N; Jittiwutikan J
    Aust N Z J Psychiatry; 1999 Feb; 33(1):94-8. PubMed ID: 10197891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of stimulants, anorectics, and related drugs on schedule-controlled behavior.
    Harris AD; Snell D; Loh HH
    Psychopharmacology (Berl); 1978 Jan; 56(1):49-55. PubMed ID: 24228
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats.
    Ko T; Evenden J
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):67-78. PubMed ID: 18825373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of psychotomimetics and psychomotor stimulants on two schedules promoting response switching in the rat.
    Evenden J
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):381-90. PubMed ID: 12373438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule.
    Chiang FK; Cheng RK; Liao RM
    Pharmacol Biochem Behav; 2015 Mar; 130():67-76. PubMed ID: 25584855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cocaine and vigilance task performance of rats: effects of delay of reinforcement.
    Grilly DM; Nocjar C
    Pharmacol Biochem Behav; 1990 Dec; 37(4):643-8. PubMed ID: 2093167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the cardiovascular effects of amineptine with those of amitriptyline and imipramine in anaesthetized rats.
    Balcioglu A; Bozkurt A; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1991; 309():64-74. PubMed ID: 1888231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.